Control of HCV Replication With iMIRs, a Novel Anti-RNAi Agent
MicroRNAs (miRNAs) serve important roles in regulating various physiological activities through RNA interference (RNAi). miR-122 is an important mediator of RNAi that is known to control hepatitis C virus (HCV) replication and is being investigated in clinical trials as a target for anti-HCV therapy...
Saved in:
Main Authors: | Saori Itami (Author), Yutaka Eguchi (Author), Takayuki Mizutani (Author), Eriko Aoki (Author), Tadaaki Ohgi (Author), Masahiko Kuroda (Author), Takahiro Ochiya (Author), Nobuyuki Kato (Author), Hiroshi I Suzuki (Author), Norifumi Kawada (Author), Yoshiki Murakami (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RNAi Therapeutic Platforms for Lung Diseases
by: Kazuyoshi Kuwano, et al.
Published: (2013) -
Life Style-Related Diseases of the Digestive System: Cell Culture System for the Screening of Anti-Hepatitis C Virus (HCV) Reagents: Suppression of HCV Replication by Statins and Synergistic Action With Interferon
by: Masanori Ikeda, et al.
Published: (2007) -
Terminal bridging of siRNA duplex at the ribose 2' position controls strand bias and target sequence preference
by: Atsushi Shibata, et al.
Published: (2023) -
Topical Use of Angiopoietin-like Protein 2 RNAi-loaded Lipid Nanoparticles Suppresses Corneal Neovascularization
by: Yukako Taketani, et al.
Published: (2016) -
The Impact of Mevastatin on HCV Replication and Autophagy of Non-Transformed HCV Replicon Hepatocytes Is Influenced by the Extracellular Lipid Uptake
by: Tiziana Vescovo, et al.
Published: (2019)